Correlation Between Ionis Pharmaceuticals and InflaRx NV

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ionis Pharmaceuticals and InflaRx NV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ionis Pharmaceuticals and InflaRx NV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ionis Pharmaceuticals and InflaRx NV, you can compare the effects of market volatilities on Ionis Pharmaceuticals and InflaRx NV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ionis Pharmaceuticals with a short position of InflaRx NV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ionis Pharmaceuticals and InflaRx NV.

Diversification Opportunities for Ionis Pharmaceuticals and InflaRx NV

-0.6
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Ionis and InflaRx is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Ionis Pharmaceuticals and InflaRx NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on InflaRx NV and Ionis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ionis Pharmaceuticals are associated (or correlated) with InflaRx NV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of InflaRx NV has no effect on the direction of Ionis Pharmaceuticals i.e., Ionis Pharmaceuticals and InflaRx NV go up and down completely randomly.

Pair Corralation between Ionis Pharmaceuticals and InflaRx NV

Given the investment horizon of 90 days Ionis Pharmaceuticals is expected to under-perform the InflaRx NV. But the stock apears to be less risky and, when comparing its historical volatility, Ionis Pharmaceuticals is 2.88 times less risky than InflaRx NV. The stock trades about -0.29 of its potential returns per unit of risk. The InflaRx NV is currently generating about -0.04 of returns per unit of risk over similar time horizon. If you would invest  250.00  in InflaRx NV on October 11, 2024 and sell it today you would lose (17.00) from holding InflaRx NV or give up 6.8% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Ionis Pharmaceuticals  vs.  InflaRx NV

 Performance 
       Timeline  
Ionis Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ionis Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
InflaRx NV 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in InflaRx NV are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, InflaRx NV showed solid returns over the last few months and may actually be approaching a breakup point.

Ionis Pharmaceuticals and InflaRx NV Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ionis Pharmaceuticals and InflaRx NV

The main advantage of trading using opposite Ionis Pharmaceuticals and InflaRx NV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ionis Pharmaceuticals position performs unexpectedly, InflaRx NV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InflaRx NV will offset losses from the drop in InflaRx NV's long position.
The idea behind Ionis Pharmaceuticals and InflaRx NV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities